6-49526591-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001010904.2(GLYATL3):c.544G>A(p.Ala182Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000458 in 1,551,744 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001010904.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLYATL3 | NM_001010904.2 | c.544G>A | p.Ala182Thr | missense_variant | 6/6 | ENST00000371197.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLYATL3 | ENST00000371197.9 | c.544G>A | p.Ala182Thr | missense_variant | 6/6 | 2 | NM_001010904.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152068Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000190 AC: 3AN: 157916Hom.: 0 AF XY: 0.0000240 AC XY: 2AN XY: 83396
GnomAD4 exome AF: 0.0000464 AC: 65AN: 1399676Hom.: 0 Cov.: 33 AF XY: 0.0000449 AC XY: 31AN XY: 690336
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152068Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74268
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.544G>A (p.A182T) alteration is located in exon 6 (coding exon 5) of the GLYATL3 gene. This alteration results from a G to A substitution at nucleotide position 544, causing the alanine (A) at amino acid position 182 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at